Valneva Se - Adr (VALN) Institutional Buying & Selling Tracker (Q2 2026)

VALN ranks #8384 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

VALN is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

20 institutions disclose a position in VALN, but none treat it as a major bet — even Vivo Capital, LLC, its most concentrated holder, allocates just 0.4% of its own portfolio to it.

UBS Group AG has added to its VALN position for two straight quarters, increasing it by $21.9K to reach $23.7K today.

Frazier Life Sciences Management, L.P. has trimmed its VALN position for two straight quarters, cutting it by $8.2M while still holding $12.0M.

VALN is down 2% today, but institutions show net buying of $5.1M this quarter — a divergence between today's price move and the underlying institutional flow.

VALN reported a net loss of $115.2M over the trailing twelve months.

• Not yet profitable — net loss of $115.2M over the trailing twelve months
• Revenue grew 3.0% year over year
• Net income declined year over year, from -$12.2M to -$115.2M
• Operating cash flow was negative, using $52.9M in cash
• Current ratio of 2.38x — enough short-term assets to cover short-term liabilities
• Liabilities run 2.76x equity — a highly leveraged balance sheet worth noting